Victor Chao

Mr. Chao joins jCyte with over 25 years of industry experience across numerous corporate operational leadership roles in CMC operations, cGMP global manufacturing, distribution, and supply chain management for multiple blockbuster biological therapies and commercial and corporate operations for ophthalmology prescription medicines, surgical devices, and biosimilars.

Mr. Chao joins jCyte from Santen Pharmaceuticals where he served as the Head of Commercial Operations for North and Latin America, responsible for Commercial Alliances and Partnerships, Market Access and Reimbursement, Trade and Distribution, and Launch Readiness for all of Santen’s ophthalmology pharmaceutical products and surgical devices. Prior to Santen, Mr. Chao was with McKesson Specialty Health as the Senior Director of Multisource Products for six years where he led, scaled, and launched numerous process initiatives and products and was responsible for McKesson’s $300M generics and biosimilars business. Before joining McKesson, Mr. Chao spent eight years at Bayer Healthcare Pharmaceuticals in leadership roles responsible for CMC operations, process engineering, and global supply chain management for their multi-billion-dollar products Betaseron® and Kogenate® across multiple manufacturing sites within the United States and Europe.

Victor holds a BS in chemical engineering from Brigham Young University and earned his MBA from The Wharton School with a dual major in strategy and entrepreneurship.